# 42 CFR 11.10 What definitions apply to this part?

42 CFR 11.10 What definitions apply to this part?, “What definitions apply to this part?”, is a CFR section of [42 CFR Part 11, Subpart A—General Provisions](https://ontology.bommaritollc.com/id/01a0f0b4-2555-7409-a092-6aa2066b5bc0); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f0b4-2ed3-775e-990a-e0c7ff53d07d>

Within: [Title 42—Public Health](https://ontology.bommaritollc.com/id/01a0f0b4-250a-76eb-a6f4-ef896ca65429) › [42 CFR Chapter I—PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://ontology.bommaritollc.com/id/01a0f0b4-253a-731e-aa05-21dec43548da) › [42 CFR Chapter I, Subchapter A—GENERAL PROVISIONS](https://ontology.bommaritollc.com/id/01a0f0b4-253c-7465-b4d3-a5f997feaa66) › [42 CFR Part 11—Clinical trials registration and results information submission](https://ontology.bommaritollc.com/id/01a0f0b4-2bcd-762e-a6a6-7cbdd10b0b4e) › [42 CFR Part 11, Subpart A—General Provisions](https://ontology.bommaritollc.com/id/01a0f0b4-2555-7409-a092-6aa2066b5bc0)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-section 42 CFR 11.10](https://ontology.bommaritollc.com/id/01a0f0b4-2ed4-7746-8642-18ba37f49d12)
- `eli:cites`:
  - [21 U.S.C. 321 Definitions; generally](https://ontology.bommaritollc.com/id/01a0f06c-cc8c-7030-ab68-1def0b197dcb)
  - [21 U.S.C. 355 New drugs](https://ontology.bommaritollc.com/id/01a0f06c-ccd6-7038-b7ea-5f9e1b3b3f50)
  - [21 U.S.C. 360 Registration of producers of drugs or devices](https://ontology.bommaritollc.com/id/01a0f06c-ccfb-75a5-8f8d-2899cf8ac727)
  - [21 U.S.C. 360e Premarket approval](https://ontology.bommaritollc.com/id/01a0f06c-cd07-7789-8906-93aab0532034)
  - [21 U.S.C. 360j General provisions respecting control of devices intended for human use](https://ontology.bommaritollc.com/id/01a0f06c-cd14-70a5-a599-4fff974986bc)
  - [21 U.S.C. 360l Postmarket surveillance](https://ontology.bommaritollc.com/id/01a0f06c-cd17-76ed-89af-389751edcbcb)
  - [21 U.S.C. 360bbb Expanded access to unapproved therapies and diagnostics](https://ontology.bommaritollc.com/id/01a0f06c-cd38-7075-88aa-4ae03ffd903d)
  - [42 U.S.C. 262 Regulation of biological products](https://ontology.bommaritollc.com/id/01a0f07c-d9ca-7203-a1d8-2d79c0329140)
  - [42 U.S.C. 282 Director of National Institutes of Health](https://ontology.bommaritollc.com/id/01a0f07c-da6f-7067-961a-ab05df754c84)
  - [21 CFR Part 3—Product jurisdiction](https://ontology.bommaritollc.com/id/01a0f094-b7dc-7010-b821-be4791210aae)
  - [21 CFR Part 50—Protection of human subjects](https://ontology.bommaritollc.com/id/01a0f094-b7f0-7092-8cfc-6d60da0417f5)
  - [21 CFR Part 56—Institutional Review Boards](https://ontology.bommaritollc.com/id/01a0f094-b7f2-72a4-82d6-ac180848fce4)
  - [21 CFR Part 812—Investigational device exemptions](https://ontology.bommaritollc.com/id/01a0f094-b896-7341-a342-c3a0aea5ee4f)
  - [21 CFR 50.3 Definitions.](https://ontology.bommaritollc.com/id/01a0f094-bbd8-7562-adf9-dee6458dfb4e)
  - [21 CFR 312.3 Definitions and interpretations.](https://ontology.bommaritollc.com/id/01a0f094-c48d-7311-98ea-d76ee37e8fc3)
  - [21 CFR 312.21 Phases of an investigation.](https://ontology.bommaritollc.com/id/01a0f094-c492-765f-a6aa-7eb9a8359e5d)
  - [21 CFR 312.23 IND content and format.](https://ontology.bommaritollc.com/id/01a0f094-c494-74e2-9ba1-bcdd75647f2a)
  - [21 CFR 312.32 IND safety reporting.](https://ontology.bommaritollc.com/id/01a0f094-c496-70c7-9713-a23940cea934)
  - [21 CFR 312.85 Phase 4 studies.](https://ontology.bommaritollc.com/id/01a0f094-c4ae-77a9-9fac-9f11e4b982ec)
  - [21 CFR 312.310 Individual patients, including for emergency use.](https://ontology.bommaritollc.com/id/01a0f094-c4b7-71ba-85f3-71c14dbbae2a)
  - [21 CFR 312.315 Intermediate-size patient populations.](https://ontology.bommaritollc.com/id/01a0f094-c4b8-71aa-9430-5d1496149607)
  - [21 CFR 312.320 Treatment IND or treatment protocol.](https://ontology.bommaritollc.com/id/01a0f094-c4b9-7751-a519-1cc468fb4e3b)
  - [42 CFR 11.28 What constitutes clinical trial registration information?](https://ontology.bommaritollc.com/id/01a0f0b4-2ed8-753a-87d1-ae5ce90cf341)
  - [42 CFR 11.35 By when will the NIH Director post clinical trial registration information submitted under § 11.28?](https://ontology.bommaritollc.com/id/01a0f0b4-2ed9-7147-839b-5b5c81dc209a)
  - [42 CFR 11.48 What constitutes clinical trial results information?](https://ontology.bommaritollc.com/id/01a0f0b4-2edd-7032-b9a4-afa5962e48a5)
  - [42 CFR 11.60 What requirements apply to the voluntary submission of clinical trial information for clinical trials of FDA-regulated drug products (including biological products) and device products?](https://ontology.bommaritollc.com/id/01a0f0b4-2ee1-734c-b286-95cdcba7a615)
  - [42 CFR 11.64 When must clinical trial information submitted to ClinicalTrials.gov be updated or corrected?](https://ontology.bommaritollc.com/id/01a0f0b4-2ee3-7007-bc04-89a04936aa31)
  - [45 CFR Part 46—Protection of human subjects](https://ontology.bommaritollc.com/id/01a0f0b9-e30b-74dc-bed4-46cc6c9702bf)
  - [45 CFR 46.102 Definitions for purposes of this policy.](https://ontology.bommaritollc.com/id/01a0f0b9-e83c-72c8-850d-237a9b6a09b6)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title42-vol1](https://ontology.bommaritollc.com/id/01a0f0b4-2ed3-775e-990a-e0c640771cb6)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0b4-6694-7171-866e-56a205eb3fda)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d1-8ede-7507-8847-dd4aa690eec1)
  - [evidence from https://www.govinfo.gov/link/cfr/42/11?sectionnum=10&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f17-f97e-7056-98b2-a742812f039c)
- `schema:isPartOf`: [42 CFR Part 11, Subpart A—General Provisions](https://ontology.bommaritollc.com/id/01a0f0b4-2555-7409-a092-6aa2066b5bc0)
- `schema:legislationIdentifier`: 42 CFR 11.10
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [CFR section](https://ontology.bommaritollc.com/vocab/leg/cfrSection)
- `schema:name`: What definitions apply to this part?
- `schema:url`: [https://www.govinfo.gov/link/cfr/42/11?sectionnum=10&year=mostrecent&link-type=details](https://www.govinfo.gov/link/cfr/42/11?sectionnum=10&year=mostrecent&link-type=details)
- `skos:prefLabel`: 42 CFR 11.10 What definitions apply to this part?

## Elsewhere

- [Official page](https://www.govinfo.gov/link/cfr/42/11?sectionnum=10&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/CFR-2025-title42-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Cited by (4; `eli:cites`):
  - [42 CFR 11.28 What constitutes clinical trial registration information?](https://ontology.bommaritollc.com/id/01a0f0b4-2ed8-753a-87d1-ae5ce90cf341)
  - [42 CFR 11.48 What constitutes clinical trial results information?](https://ontology.bommaritollc.com/id/01a0f0b4-2edd-7032-b9a4-afa5962e48a5)
  - [42 CFR 11.60 What requirements apply to the voluntary submission of clinical trial information for clinical trials of FDA-regulated drug products (including biological products) and device products?](https://ontology.bommaritollc.com/id/01a0f0b4-2ee1-734c-b286-95cdcba7a615)
  - [42 CFR 11.64 When must clinical trial information submitted to ClinicalTrials.gov be updated or corrected?](https://ontology.bommaritollc.com/id/01a0f0b4-2ee3-7007-bc04-89a04936aa31)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f0b4-2ed3-775e-990a-e0c7ff53d07d.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f0b4-2ed3-775e-990a-e0c7ff53d07d.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f0b4-2ed3-775e-990a-e0c7ff53d07d.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f0b4-2ed3-775e-990a-e0c7ff53d07d)
Cite as: 42 CFR 11.10 What definitions apply to this part?. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f0b4-2ed3-775e-990a-e0c7ff53d07d
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
